Autolus Therapeutics announces the appointment of Dr. William D. Young as a Non-Executive Director
November 15, 2021 07:00 ET
|
Autolus Therapeutics plc
LONDON, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...